PDE1C Antikörper (AA 284-630)
Kurzübersicht für PDE1C Antikörper (AA 284-630) (ABIN7570720)
Target
Alle PDE1C Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 284-630
-
Verwendungszweck
- Anti-PDE1C Polyclonal antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human PDE1C (Arg284-Asp630).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- PDE1C (phosphodiesterase 1C, Calmodulin-Dependent 70kDa (PDE1C))
-
Andere Bezeichnung
- PDE1C
-
Hintergrund
- PDE1C,Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C,Cam-PDE 1C,3',5'-cyclic-GMP phosphodiesterase,3',5'-cyclic-AMP phosphodiesterase,Hcam3,
-
UniProt
- Q14123
-
Pathways
- EGFR Signaling Pathway, Neurotrophin Signalübertragung, Negative Regulation of Hormone Secretion, cAMP Metabolic Process, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma
Target
-